These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18685919)

  • 21. IVIG--mechanisms of action.
    Simon HU; Späth PJ
    Allergy; 2003 Jul; 58(7):543-52. PubMed ID: 12823109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy.
    Lemm G
    Neurology; 2002 Dec; 59(12 Suppl 6):S28-32. PubMed ID: 12499468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
    Stohl W; Elliot JE
    Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunoglobulins and physiopathology: actual indications].
    Mouthon L; Guilpain P
    Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
    Gold R; Hartung HP; Toyka KV
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IVIg in other autoimmune neurological disorders: current status and future prospects.
    Dalakas M
    J Neurol; 2008 Jul; 255 Suppl 3():12-6. PubMed ID: 18685921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.
    Nachbaur D; Herold M; Eibl B; Glassl H; Schwaighofer H; Huber C; Gächter A; Pichl M; Niederwieser D
    Immunology; 1997 Feb; 90(2):212-8. PubMed ID: 9135549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
    Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
    Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
    Trebst C; Brunhorn K; Lindner M; Windhagen A; Stangel M
    Eur J Neurol; 2006 Dec; 13(12):1359-63. PubMed ID: 17116220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of IVIg in autoimmune neuropathies: the latest evidence.
    Hughes R
    J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].
    Galeotti C; Maddur MS; Kazatchkine MD; Mouthon L; Kaveri SV
    Transfus Clin Biol; 2009 May; 16(2):75-9. PubMed ID: 19443254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.
    Mitrevski M; Marrapodi R; Camponeschi A; Lazzeri C; Todi L; Quinti I; Fiorilli M; Visentini M
    Immunol Res; 2014 Dec; 60(2-3):330-8. PubMed ID: 25407649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.